FULGENT GENETICS INC

Fulgent Genetics insiders sell shares for liquidity, not panic—insider sales remain steady amid rising stock, a sign of confidence in precision‑medicine growth.

Fulgent Genetics insider selling: CEO Ming Hsieh’s recent trades show risk‑aversion, potential lock‑in events and a fragile valuation—what it means for investors.

CEO Ming Hsieh’s modest insider sales show confidence in Fulgent Genetics’ growth plans, underscoring long‑term alignment with shareholders.